Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Name: Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
Published: 2022
License: Public Domain

Newave Pharmaceutical Inc · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

acute-myeloid-leukemia multiple-myeloma

non hodgkin lymphoma, richter transformation, multiple myeloma, t-cell-prolymphocytic leukemia, acute myeloid leukemia, acute lymphocytic leukemia, myeodysplastic syndrome, myelodysplastic/myeloproliferative neoplasm, myelofibrosis, chronic lymphocytic leukemia, small lymphocytic lymphoma, chronic myelomonocytic leukemia-2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 916522
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.